NBI與AMEX生技指數各跌4.47%、3.61%,NYSE藥業指數跌0.61%。
本刊精選29檔美國生技股,按照當周漲跌幅排序,提供讀者觀察市場波動。
2021年02月-美股7日漲跌幅排名(0226-0305) |
|||||
| 個股代碼 | 名稱 | 本周收價(美元) | 上周收價(美元) | 漲跌幅 | 備註 |
| IBB | iShares Nasdaq Biotechnology ETF | 150.15 | 156.93 | -4.32% | |
| #NBI | NASDAQ生物科技指數 | 4716.25 | 4936.78 | -4.47% | |
| #BTK | AMEX生物科技指數 | 5536.55 | 5744.01 | -3.61% | |
| 個股代碼 | 名稱 | 本周收價(美元) | 上周收價(美元) | 漲跌幅 | 分類 |
| CI | Cigna | 230.62 | 209.9 | 9.87% | 醫療保健 |
| GILD | Gilead Sciences | 64.62 | 61.4 | 5.24% | 生技 |
| GSK | GlaxoSmithKline PLC | 34.91 | 33.61 | 3.87% | 製藥 |
| PFE | Pfizer | 34.39 | 33.49 | 2.69% | 製藥 |
| REGN | Regeneron Pharmaceuticals | 461.57 | 450.57 | 2.44% | 製藥 |
| SNY | Sanofi | 46.59 | 45.89 | 1.53% | 製藥 |
| MACK | Merrimack Pharmaceuticals | 6.57 | 6.48 | 1.39% | 台灣授權 |
| AMGN | Amgen | 227.73 | 224.92 | 1.25% | 生技 |
| LLY | Eli Lilly and | 206.92 | 204.89 | 0.99% | 製藥 |
| MRK | Merck | 73.13 | 72.62 | 0.70% | 製藥:PD-1 |
| AZN | Astrazeneca PLC | 48.06 | 48.38 | -0.66% | 製藥 |
| BIIB | Biogen | 270.71 | 272.88 | -0.80% | 生技 |
| ABBV | AbbVie | 106.7 | 107.74 | -0.97% | 製藥 |
| BMY | Bristol-Myers Squibb | 60.43 | 61.33 | -1.47% | 製藥:PD-1 |
| JNJ | Johnson & Johnson | 156.1 | 158.46 | -1.49% | 製藥 |
| AKBA | Akebia Therapeutics | 3.405 | 3.46 | -1.59% | 製藥(併KERX) |
| ALXN | Alexion Pharmaceuticals | 150.1 | 152.75 | -1.73% | 製藥 |
| ABT | Abbott Laboratories | 117.25 | 119.78 | -2.11% | 製藥 |
| NVS | Novartis AG | 84.01 | 85.91 | -2.21% | 製藥 |
| TEVA | Teva Pharmaceutical Industries | 10.52 | 10.76 | -2.23% | 製藥 |
| EDIT | Editas Medicine | 41.63 | 43.86 | -5.08% | 基因編輯 |
| CLVS | Clovis Oncology | 5.58 | 5.99 | -6.84% | 製藥:PARP |
| BLUE | bluebird bio | 28.68 | 31.1 | -7.78% | 生技:CART |
| CRSP | CRISPR Therapeutics AG | 114.65 | 125.69 | -8.78% | 基因編輯 |
| ILMN | Illumina | 398.85 | 439.41 | -9.23% | 生技:醫材 |
| NTLA | Intellia Therapeutics | 51.81 | 60.46 | -14.31% | 基因編輯 |
| CLLS | Cellectis S.A. | 18.19 | 21.5 | -15.40% | 生技:CART |
| ASLN | ASLAN Pharmaceuticals | 3.42 | 4.43 | -22.80% | 製藥(臺美雙掛牌) |